Rocket One Inc. RKTO
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
1/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$12.4M | -$8.2M | -$8.0M | -$11.1M | -$14.1M |
| Net income | -$12.5M | -$8.2M | -$8.1M | -$11.4M | -$14.3M |
| Operating cash flow | -$9.8M | -$7.0M | -$8.4M | -$9.3M | -$12.1M |
| Total assets | $7.6M | $7.7M | $10.2M | $7.7M | $11.0M |
| Total liabilities | $1.5M | $833,906 | $704,983 | $1.6M | $1.1M |
| Shareholders' equity | $6.2M | $6.9M | $9.5M | $6.1M | $9.9M |
| Ratios | |||||
| Return on assets | -164.0% | -106.2% | -79.1% | -146.9% | -130.3% |
| Return on equity | -202.7% | -119.0% | -85.0% | -186.3% | -144.8% |
| Current ratio | 4.72 | 9.20 | 14.96 | 5.56 | 12.19 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001711786 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.